NVA237 BID Versus Placebo Twelve-week Efficacy Study

PHASE3CompletedINTERVENTIONAL
Enrollment

432

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

NVA237

NVA237 (Glycopyrronioum bromide) as a powder for inhalation in single-dose capsules

DRUG

Placebo

Placebo powder for inhalation in single-dose capsules (matching those for NVA237).

Trial Locations (59)

10003

Novartis Investigative Site, New York

10028

Novartis Investigative Site, New York

11021

Novartis Investigative Site, Great Neck

11229

Novartis Investigative Site, Brooklyn

11234

Novartis Investigative Site, Brooklyn

11758

Novartis Investigative Site, Massapequa

12553

Novartis Investigative Site, New Windsor

15243

Novartis Investigative Site, Pittsburgh

16684

Novartis Investigative Site, Tipton

19047

Novartis Investigative Site, Langhorne

19464

Novartis Investigative Site, Pottstown

23219

Novartis Investigative Site, Richmond

23233

Novartis Investigative Site, Richmond

28207

Novartis Investigative Site, Charlotte

29707

Novartis Investigative Site, Fort Mill

29732

Novartis Investigative Site, Rock Hll

30094

Novartis Investigative Site, Conyers

32127

Novartis Investigative Site, Port Orange

32444

Novartis Investigative Site, Lynn Haven

32789

Novartis Investigative Site, Winter Park

33173

Novartis Investigative Site, Miami

40509

Novartis Investigative Site, Lexington

43213

Novartis Investigative Site, Columbus

45231

Novartis Investigative Site, Cincinnati

45242

Novartis Investigative Site, Cincinnati

45245

Novartis Investigative Site, Cincinnati

47714

Novartis Investigative Site, Evansville

55402

Novartis Investigative Site, Minneapolis

55441

Novartis Investigative Site, Plymouth

60076

Novartis Investigative Site, Skokie

60305

Novartis Investigative Site, River Forest

63128

Novartis Investigative Site, St Louis

63141

Novartis Investigative Site, St Louis

63301

Novartis Investigative Site, Saint Charles

68025

Novartis Investigative Site, Fremont

68114

Novartis Investigative Site, Omaha

68510

Novartis Investigative Site, Lincoln

70584

Novartis Investigative Site, Sunset

76210

Novartis Investigative Site, Denton

78229

Novartis Investigative Site, San Antonio

80033

Novartis Investigative Site, Wheat Ridge

80304

Novartis Investigative Site, Boulder

84047

Novartis Investigative Site, Midvale

85224

Novartis Investigative Site, Chandler

87108

Novartis Investigative Site, Albuquerque

92835

Novartis Investigative Site, Fullerton

92886

Novartis Investigative Site, Yorba Linda

93726

Novartis Investigative Site, Fresno

97213

Novartis Investigative Site, Portland

97504

Novartis Investigative Site, Medford

98405

Novartis Investigative Site, Tacoma

Unknown

Novartis Investigative Site, *See Various Dept.'s*

92886-7921

Novartis Investigative Site, Yorba Linda

02720

Novartis Investigative Site, Fall River

02747

Novartis Investigative Site, North Dartmouth

08003

Novartis Investigative Site, Cherry Hill

97504-8741

Novartis Investigative Site, Medford

02914

Novartis Investigative Site, East Providence

05403

Novartis Investigative Site, South Burlington

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY